You are here

Clinical Trials: Heart Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Monday, December 28, 2015 - 12:00
Condition:   Heart Failure
Interventions:   Procedure: CABG surgery;   Procedure: AADC therapy
Sponsor:   Helsinki University Central Hospital
Not yet recruiting - verified January 2016
Posted: Sunday, December 13, 2015 - 12:00
Condition:   Chronic Ischemic Cardiomyopathy
Interventions:   Biological: hUC-MSCs+Injectable collagen scaffold+CABG;   Biological: hUC-MSCs+CABG;   Procedure: CABG
Sponsors:   Chinese Academy of Sciences;   The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Recruiting - verified December 2015
Posted: Tuesday, September 1, 2015 - 12:00
Condition:   Coronary Arteriosclerosis
Interventions:   Device: OrbusNeich Combo stent™;   Device: sirolimus-eluting stent system
Sponsors:   OrbusNeich;   CCRF Inc., Beijing, China;   OrbusNeich Medical (Shenzhen), Co. Ltd.
Recruiting - verified March 2016
Posted: Monday, July 20, 2015 - 12:00
Condition:   Heart Failure
Interventions:   Biological: Cardiology Stem Cell Centre Adipose Stem Cell (CSCC_ASC);   Biological: Placebo
Sponsor:   JKastrup
Recruiting - verified March 2017
Posted: Wednesday, July 15, 2015 - 12:00
Condition:   Ischemic Cardiomyopathy
Interventions:   Biological: Mesenchymal Stem Cells (MSC);   Biological: Cardiac Stem Cells (CSC);   Biological: Placebo (Plasmalyte A)
Sponsors:   The University of Texas Health Science Center, Houston;   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified January 2016
Posted: Tuesday, July 14, 2015 - 12:00
Conditions:   Myocardial Infarction;   Acute Myocardial Infarction;   Ischemic Cardiomyopathy
Intervention:   Biological: BMMSCs
Sponsors:   Academy Military Medical Science, China;   Sun Yat-sen University
Not yet recruiting - verified July 2015
Posted: Sunday, June 21, 2015 - 12:00
Condition:   Refractory Angina Pectoris
Interventions:   Device: remote ischemic conditioning (TDFT-12-A2);   Drug: Optimal medical treatment
Sponsor:   Navy General Hospital, Beijing
Recruiting - verified July 2015
Posted: Monday, June 8, 2015 - 12:00
Conditions:   Type 2 Diabetes;   Impaired Renal Function
Interventions:   Drug: Linagliptin;   Drug: Placebo
Sponsors:   George Washington University;   Boehringer Ingelheim
Recruiting - verified April 2015
Posted: Monday, June 1, 2015 - 12:00
Conditions:   Coronary Disease;   Heart Transplant
Intervention:   Biological: Mesenchymal cell therapy
Sponsor:   Assistance Publique - Hôpitaux de Paris
Recruiting - verified June 2015
Posted: Wednesday, May 27, 2015 - 12:00
Condition:   Chronic Myocardial Ischemia
Interventions:   Drug: Autologous MSC from bone marrow;   Drug: Placebo comparator
Sponsor:   University Hospital, Toulouse
Recruiting - verified April 2016